NO20081098L - Sulphonamide derivatives - Google Patents
Sulphonamide derivativesInfo
- Publication number
- NO20081098L NO20081098L NO20081098A NO20081098A NO20081098L NO 20081098 L NO20081098 L NO 20081098L NO 20081098 A NO20081098 A NO 20081098A NO 20081098 A NO20081098 A NO 20081098A NO 20081098 L NO20081098 L NO 20081098L
- Authority
- NO
- Norway
- Prior art keywords
- het
- formula
- aryl
- alkyl
- aroyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20055498A FI20055498A0 (fi) | 2005-09-16 | 2005-09-16 | Sulfonamidijohdannaisia |
PCT/FI2006/050395 WO2007034035A1 (fr) | 2005-09-16 | 2006-09-15 | Dérivés sulfonamide |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081098L true NO20081098L (no) | 2008-05-30 |
Family
ID=35151465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081098A NO20081098L (no) | 2005-09-16 | 2008-03-03 | Sulphonamide derivatives |
Country Status (13)
Country | Link |
---|---|
US (1) | US20090023735A1 (fr) |
EP (1) | EP1924554A4 (fr) |
JP (1) | JP2009507904A (fr) |
KR (1) | KR20080043847A (fr) |
CN (1) | CN101268041A (fr) |
AU (1) | AU2006293867A1 (fr) |
CA (1) | CA2622086A1 (fr) |
FI (1) | FI20055498A0 (fr) |
IL (1) | IL190012A0 (fr) |
NO (1) | NO20081098L (fr) |
RU (1) | RU2008114853A (fr) |
WO (1) | WO2007034035A1 (fr) |
ZA (1) | ZA200801919B (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20075258A0 (fi) * | 2007-04-17 | 2007-04-17 | Biotie Therapies Corp | Menetelmä integriiniinhibiittorirespondereiden seulomiseksi |
WO2009096198A1 (fr) * | 2008-02-01 | 2009-08-06 | Pharma Ip Limited Liability Intermediary Corporations | Nouveau derive de biaryle |
CN103373985B (zh) | 2008-06-19 | 2015-10-28 | 武田药品工业株式会社 | 杂环化合物及其用途 |
LT2540728T (lt) | 2010-02-17 | 2019-06-25 | Takeda Pharmaceutical Company Limited | Heterociklinis junginys |
TWI570122B (zh) | 2011-06-22 | 2017-02-11 | 武田藥品工業股份有限公司 | 稠合雜環化合物之結晶 |
CN103193691B (zh) * | 2012-01-06 | 2017-08-25 | 中国科学院上海药物研究所 | 磺胺类化合物、药物组合物及其制法和应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0655708B2 (ja) * | 1985-05-13 | 1994-07-27 | 三井東圧化学株式会社 | スルホンアミド系化合物及び農業用殺菌剤 |
DE3535167A1 (de) * | 1985-10-02 | 1987-04-09 | Boehringer Mannheim Gmbh | Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel |
ATE167473T1 (de) * | 1990-08-20 | 1998-07-15 | Eisai Co Ltd | Sulfonamid-derivate |
DE4037112A1 (de) * | 1990-11-22 | 1992-05-27 | Thomae Gmbh Dr K | Neue pyridylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
US5286736A (en) * | 1990-11-22 | 1994-02-15 | Dr. Karl Thomae Gmbh | Pyridyl compounds and pharmaceutical compositions containing these compounds |
US6541498B2 (en) * | 1993-05-20 | 2003-04-01 | Texas Biotechnology | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
US5939451A (en) * | 1996-06-28 | 1999-08-17 | Hoffmann-La Roche Inc. | Use of sulfonamides |
US6284923B1 (en) * | 1997-08-22 | 2001-09-04 | Tularik Inc | Substituted benzene compounds as antiproliferative and cholesterol lowering action |
US6191170B1 (en) * | 1998-01-13 | 2001-02-20 | Tularik Inc. | Benzenesulfonamides and benzamides as therapeutic agents |
DE19827640A1 (de) * | 1998-06-20 | 1999-12-23 | Bayer Ag | 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone |
ATE240940T1 (de) * | 1998-09-23 | 2003-06-15 | Tularik Inc | Arylsulfonanilid-harnstoffe |
HUP0300544A3 (en) * | 2000-02-03 | 2005-03-29 | Eisai Co Ltd | Pharmaceutical compositions containing integrin expression inhibitors |
DE60217300T2 (de) * | 2001-02-21 | 2007-10-04 | Eisai Co., Ltd. | Verfahren zur untersuchung der wirkung eines angionegesis-hemmers unter vermittlung durch hemmung der integrin-expression |
JP2005022976A (ja) * | 2001-07-18 | 2005-01-27 | Ajinomoto Co Inc | カルボン酸誘導体 |
WO2003099773A1 (fr) * | 2002-05-24 | 2003-12-04 | Millennium Pharmaceuticals, Inc. | Inhibiteurs de ccr9 et utilisation de ceux-ci |
US7227035B2 (en) * | 2002-11-18 | 2007-06-05 | Chemocentryx | Bis-aryl sulfonamides |
KR100866456B1 (ko) * | 2002-11-18 | 2008-10-31 | 케모센트릭스 | 아릴 술폰아마이드 |
WO2004073619A2 (fr) * | 2003-02-14 | 2004-09-02 | Smithkline Beecham Corporation | Antagonistes du recepteur ccr8 |
GB0316128D0 (en) * | 2003-07-10 | 2003-08-13 | Univ Aston | Novel sulfonamide compounds |
WO2005090297A1 (fr) * | 2004-03-19 | 2005-09-29 | Biotie Therapies Corporation | Derives sulfonamides |
-
2005
- 2005-09-16 FI FI20055498A patent/FI20055498A0/fi not_active Application Discontinuation
-
2006
- 2006-09-15 KR KR1020087006378A patent/KR20080043847A/ko not_active Application Discontinuation
- 2006-09-15 CA CA002622086A patent/CA2622086A1/fr not_active Abandoned
- 2006-09-15 EP EP06820086A patent/EP1924554A4/fr not_active Withdrawn
- 2006-09-15 AU AU2006293867A patent/AU2006293867A1/en not_active Abandoned
- 2006-09-15 US US12/066,950 patent/US20090023735A1/en not_active Abandoned
- 2006-09-15 CN CNA2006800341940A patent/CN101268041A/zh active Pending
- 2006-09-15 JP JP2008530557A patent/JP2009507904A/ja not_active Withdrawn
- 2006-09-15 RU RU2008114853/04A patent/RU2008114853A/ru not_active Application Discontinuation
- 2006-09-15 WO PCT/FI2006/050395 patent/WO2007034035A1/fr active Application Filing
-
2008
- 2008-02-29 ZA ZA200801919A patent/ZA200801919B/xx unknown
- 2008-03-03 NO NO20081098A patent/NO20081098L/no not_active Application Discontinuation
- 2008-03-06 IL IL190012A patent/IL190012A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2009507904A (ja) | 2009-02-26 |
EP1924554A1 (fr) | 2008-05-28 |
EP1924554A4 (fr) | 2010-07-21 |
RU2008114853A (ru) | 2009-10-27 |
IL190012A0 (en) | 2009-09-22 |
WO2007034035A1 (fr) | 2007-03-29 |
AU2006293867A1 (en) | 2007-03-29 |
US20090023735A1 (en) | 2009-01-22 |
CN101268041A (zh) | 2008-09-17 |
KR20080043847A (ko) | 2008-05-19 |
ZA200801919B (en) | 2009-10-28 |
CA2622086A1 (fr) | 2007-03-29 |
FI20055498A0 (fi) | 2005-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081098L (no) | Sulphonamide derivatives | |
NO20092770L (no) | Nye aminopyrimidinderivater som PLK1-inhibitorer | |
ATE293101T1 (de) | Piperidine zur verwendung als orexin rezeptor antagonisten | |
HRP20070529T3 (en) | Imidazole derivatives as glutmate receptor antagonists | |
NO20053974L (no) | Tienopyrimidinforbindelser og anvendelse derav. | |
NO20070343L (no) | N-(1 -(1 -benzyl-4-fenyl-1 H-imidazol-2-yl)-2,2-dimetylpropyl)benzamid derivater og relaterte forbindelser som kinesin spindelprotein (KSP) inhibitorer for behandling av kreft | |
NO20063681L (no) | Aryloksyalkylkarbamattype derivater, fremgangsmate for fremstilling derav og anvendelse av derivatene i terapeutiske midler | |
MEP22008A (en) | Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics | |
HRP20090151T3 (en) | Indozolone derivatives as 11b-hsd1 inhibitors | |
RS51189B (sr) | Supstituisani derivati propenil piperazina kao novi inhibitori histonske deacetilaze | |
PE20061316A1 (es) | Derivados de pirazol como antagonistas del receptor de progesterona | |
CO5640099A2 (es) | Derivados de oxifenilo aromaticos y de sulfanilfenilo aromaticos | |
TW200744994A (en) | Insecticidal 3-acylaminobenzanilides | |
AR054688A1 (es) | Alquil-piridinas como inhibidores 11-beta de la diabetes | |
TW200633991A (en) | Chemical compounds | |
ME01395B (fr) | Procédé de synthèse du (1S)-4,5-diméthoxy-1-(méthylaminométhyl)-benzocyclobutane et de ses sels d'addition, et application à la synthèse de l'ivabradine et de ses sels d'addition à un acide pharmaceutiquement acceptable | |
RU2014137257A (ru) | Способ получения сульфилиминовых соединений | |
GEP20105071B (en) | Processes for preparing 4-(phenoxy-5-methyl-pyrimidin-4-yloxy) piperidine-1-carboxylic acid derivatives and related compounds | |
PE20140609A1 (es) | Diazacarbazoles y metodos de uso | |
NO20053449L (no) | 3-substituerte 4-pyrimidonderivater | |
NZ599132A (en) | Indazole and pyrazolopyridine compounds as ccr1 receptor antagonists | |
WO2014133414A3 (fr) | Agonistes hétérocycliques des récepteurs d'acides biliaires tgr5, composition pharmaceutique, procédé de fabrication et d'utilisation | |
WO2009095792A3 (fr) | Dérivés d'hétéroarylamide diazépinopyrimidone substitués | |
JP2005502714A5 (fr) | ||
JP2016510781A (ja) | RORcモジュレーターとしてのアリールスルファミド及びスルファミン酸誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |